JP2008535800A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535800A5
JP2008535800A5 JP2008501331A JP2008501331A JP2008535800A5 JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5 JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008501331 A JP2008501331 A JP 2008501331A JP 2008535800 A5 JP2008535800 A5 JP 2008535800A5
Authority
JP
Japan
Prior art keywords
fel
seq
chain
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008501331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535800A (ja
JP5302671B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/060845 external-priority patent/WO2006097530A2/en
Publication of JP2008535800A publication Critical patent/JP2008535800A/ja
Publication of JP2008535800A5 publication Critical patent/JP2008535800A5/ja
Application granted granted Critical
Publication of JP5302671B2 publication Critical patent/JP5302671B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008501331A 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用 Expired - Fee Related JP5302671B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18
US60/662,918 2005-03-18
PCT/EP2006/060845 WO2006097530A2 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013048847A Division JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Publications (3)

Publication Number Publication Date
JP2008535800A JP2008535800A (ja) 2008-09-04
JP2008535800A5 true JP2008535800A5 (OSRAM) 2009-05-07
JP5302671B2 JP5302671B2 (ja) 2013-10-02

Family

ID=36843236

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008501331A Expired - Fee Related JP5302671B2 (ja) 2005-03-18 2006-03-17 ネコアレルゲンコンジュゲートとその使用
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013048847A Pending JP2013155176A (ja) 2005-03-18 2013-03-12 ネコアレルゲンコンジュゲートとその使用

Country Status (19)

Country Link
US (3) US7767212B2 (OSRAM)
EP (1) EP1868642B1 (OSRAM)
JP (2) JP5302671B2 (OSRAM)
KR (1) KR20070112225A (OSRAM)
CN (2) CN101141979B (OSRAM)
AU (1) AU2006224529B2 (OSRAM)
BR (1) BRPI0608455A2 (OSRAM)
CA (1) CA2599218C (OSRAM)
CY (1) CY1114171T1 (OSRAM)
DK (1) DK1868642T3 (OSRAM)
ES (1) ES2424229T3 (OSRAM)
IL (1) IL185103A0 (OSRAM)
MX (1) MX2007011160A (OSRAM)
NZ (1) NZ561040A (OSRAM)
PL (1) PL1868642T3 (OSRAM)
PT (1) PT1868642E (OSRAM)
RU (1) RU2414239C2 (OSRAM)
WO (1) WO2006097530A2 (OSRAM)
ZA (1) ZA200707413B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
EP2196217A1 (en) 2001-09-14 2010-06-16 Cytos Biotechnology AG Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
WO2004007538A2 (en) * 2002-07-17 2004-01-22 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
DK1524994T3 (da) * 2002-07-19 2011-08-15 Cytos Biotechnology Ag Vaccinesammensætninger indeholdende amyloid beta 1-6-antigen-arrays
NZ561040A (en) * 2005-03-18 2009-04-30 Cytos Biotechnology Ag Cat allergen fusion proteins and use thereof
JP5484732B2 (ja) * 2005-12-14 2014-05-07 サイトス バイオテクノロジー アーゲー 過敏症の治療のための免疫賦活性核酸パッケージ粒子
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
KR101552227B1 (ko) 2006-06-12 2015-09-10 사이토스 바이오테크놀로지 아게 올리고뉴클레오티드를 ｒｎａ 박테리오파지의 바이러스-유사 입자로 패키징하는 방법
DK2601969T3 (en) 2006-09-29 2016-04-18 Takeda Vaccines Inc Norovirus vaccine formulations
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
HUE034431T2 (en) * 2007-07-09 2018-02-28 Nestec Sa Procedures to reduce allergies caused by environmental allergens
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
SG184733A1 (en) 2007-09-18 2012-10-30 Ligocyte Pharmaceuticals Inc Method of conferring a protective immune response to norovirus
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
CA2733589C (en) 2008-08-08 2021-07-13 Ligocyte Pharmaceuticals, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
GB2498323B8 (en) * 2009-11-05 2014-08-06 Hal Padgett Generation of antigenic virus-like particles through protein-protein linkages
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
DK3299030T3 (da) 2011-07-11 2022-09-05 Takeda Vaccines Inc Parenterale norovirus-vaccineformuleringer
BR112014013035A2 (pt) 2011-12-22 2018-10-09 Hoffmann La Roche métodos de seleção de células, conjuntos de expressão bicistrônica, células eucarióticas, vetores lentivirais, uso de vetor lentiviral, bibliotecas de ventores lentivirais e de células eucarióticas, métodos de seleção de células, fluxos de trabalho e uso de célula
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
EP3587455A1 (en) * 2012-10-23 2020-01-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
CA2922113C (en) 2013-08-23 2023-05-23 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
US20150175940A1 (en) 2013-12-19 2015-06-25 Nestec Sa Compositions and methods for reducing cat allergens in the environment
MA40824A (fr) 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
AU2016207099C1 (en) 2015-01-15 2021-02-04 University Of Copenhagen Virus-like particle with efficient epitope display
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
WO2017042241A1 (en) 2015-09-08 2017-03-16 Universität Zürich Compositions against cat allergy
DK3368068T3 (da) 2015-10-30 2021-02-22 Univ Copenhagen Viruslignende partikler med effektiv epitopdisplay
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
WO2018118713A1 (en) 2016-12-22 2018-06-28 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
EP3897711A1 (en) 2018-12-20 2021-10-27 Saiba AG Virus-like particles of cmv modified by fusion
KR20240145520A (ko) * 2022-03-18 2024-10-07 덴카 주식회사 링커에 의해 연결된 캡시드 단백질을 포함하는 바이러스 유사입자
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025139524A1 (zh) * 2023-12-28 2025-07-03 江苏众红生物工程创药研究院有限公司 猫重组变应原及其药用组合物、制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
DE68924850T2 (de) * 1988-06-14 1996-10-10 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
AU9052091A (en) 1990-12-20 1992-07-22 Smithkline Beecham Biologicals (Sa) Vaccines based on hepatitis b surface antigen
GB9114003D0 (en) * 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
AU7726094A (en) 1994-09-02 1996-03-27 Immulogic Pharmaceutical Corporation Peptide compositions capable of down regulating an antigen specific immune response
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
WO1996030523A2 (en) 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
EP1037663A2 (en) * 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
DE69929232T2 (de) * 1998-10-21 2006-08-31 The United States Government As Represented By The Department Of Health And Human Services Virusähnliche partikel zur induktion von autoantikörpern
DK1135162T3 (da) * 1998-11-30 2009-01-19 Cytos Biotechnology Ag Ordnet molekylær præsentation af allergener, fremstillingsfremgangsmåde samt anvendelse
UA77152C2 (en) 1999-09-25 2006-11-15 Method for stimulation of immune response using nucleic acid-containing immunostimulating compositions, method for treatment of cancer and method for treatment or prophylaxis of allergy or asthma
CA2407897A1 (en) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
HUP0302601A3 (en) 2000-11-16 2010-01-28 Alk Abello As Mutant allergens
ATE347376T1 (de) * 2000-12-28 2006-12-15 Biomay Prod & Handel Behandlung von allergien
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
DK1499349T3 (da) 2001-03-02 2010-04-06 Univ Rockefeller Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet
EP2196217A1 (en) 2001-09-14 2010-06-16 Cytos Biotechnology AG Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
CA2492823A1 (en) 2001-09-14 2003-03-27 Martin F. Bachmann In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
PL369863A1 (en) * 2001-11-07 2005-05-02 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
ES2316628T3 (es) * 2001-11-07 2009-04-16 Cytos Biotechnology Ag Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas.
WO2004007538A2 (en) 2002-07-17 2004-01-22 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
KR20050027168A (ko) 2002-07-19 2005-03-17 사이토스 바이오테크놀로지 아게 그렐린-캐리어 컨쥬게이트
EP1530585A2 (en) * 2002-08-22 2005-05-18 Cytos Biotechnology AG Inducible alphaviral/orip based gene expression system
JP2006520184A (ja) 2002-11-01 2006-09-07 アルカベロ アクチェセルスカプ 組換えタンパク質変種
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
CN100560719C (zh) * 2003-03-26 2009-11-18 赛托斯生物技术公司 Melan-a肽类似物-病毒样颗粒偶联物
DE602004011502T2 (de) * 2003-04-24 2009-01-22 Imvision Gmbh Rekombinantes fel d 1 allergen
AU2004255470B2 (en) * 2003-07-10 2010-08-19 Cytos Biotechnology Ag Packaged virus-like particles
NZ561040A (en) * 2005-03-18 2009-04-30 Cytos Biotechnology Ag Cat allergen fusion proteins and use thereof

Similar Documents

Publication Publication Date Title
JP2008535800A5 (OSRAM)
Jennings et al. The coming of age of virus-like particle vaccines
JP5084103B2 (ja) ハプテン担体抱合体およびその用法
JP2004522736A5 (OSRAM)
JP2008529558A5 (OSRAM)
RU2007138265A (ru) Белки, слитые с кошачьим аллергеном, и их применение
JP2008517975A (ja) 胃酸分泌抑制ポリペプチド（ｇｉｐ）抗原アッセイ及びその使用
ES2320638T3 (es) Disposicion ordenada de antigenos il-5, il-13 o eotasina, para el tratamiento de enfermedades alergicas con un componente eosinofilico.
JP2009510025A5 (OSRAM)
MXPA04011247A (es) Conjugados portadores de grelina.
JP2006504653A5 (OSRAM)
JP2008530245A5 (OSRAM)
JP2016512213A5 (OSRAM)
US20090123414A1 (en) Il-15 Antigen Arrays And Uses Thereof
JP2006516116A5 (OSRAM)
CA2925201A1 (en) Self-assembled nanoparticle vaccines
JP2011521662A5 (OSRAM)
JP2016521539A (ja) マラリアワクチン
JP2015509707A5 (OSRAM)
CN112292391A (zh) 用与细胞因子连接的ecm亲和肽治疗癌症的方法和组合物
JP2010508857A5 (OSRAM)
JP2009520758A5 (OSRAM)
JP2010538619A5 (OSRAM)
JP2010506926A5 (OSRAM)
RU2006130006A (ru) Конъюгаты грелин-носитель